SynthesisBMC cancer2019

Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis.

Xiaoying Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.